<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <title>Candida dubliniensis - UTI PathoDB</title>
    <link href="https://cdn.jsdelivr.net/npm/tailwindcss@2.2.19/dist/tailwind.min.css" rel="stylesheet">
</head>
<body class="bg-gray-50 text-gray-900">

    <header class="bg-green-600 text-white p-4 shadow-md">
        <h1 class="text-2xl font-bold text-center">Candida dubliniensis - UTI PathoDB</h1>
    </header>

    <main class="p-6 space-y-6 max-w-4xl mx-auto">

        <!-- Overview -->
        <section>
            <h2 class="text-xl font-semibold mb-2">Overview</h2>
            <p>
                <strong>Candida dubliniensis</strong> is a fungal species closely related to Candida albicans. It has been isolated from cases of oropharyngeal candidiasis, especially in HIV-infected individuals, and is also known to cause urinary tract infections (UTIs), particularly in immunocompromised patients.
            </p>
        </section>

        <!-- Characteristics -->
        <section>
            <h2 class="text-xl font-semibold mb-2">Characteristics</h2>
            <ul class="list-disc list-inside space-y-1">
                <li>Yeast-like fungus</li>
                <li>Forms germ tubes and chlamydospores, similar to Candida albicans</li>
                <li>Less virulent than Candida albicans</li>
                <li>Commonly isolated in immunocompromised hosts</li>
            </ul>
        </section>

        <!-- Pathogenicity -->
        <section>
            <h2 class="text-xl font-semibold mb-2">Pathogenicity</h2>
            <p>
                Candida dubliniensis primarily causes infections in individuals with weakened immune systems. Its role in UTIs is increasing, particularly in patients with catheters or those receiving broad-spectrum antibiotics. Biofilm formation contributes to its pathogenic potential.
            </p>
        </section>

        <!-- Clinical Significance -->
        <section>
            <h2 class="text-xl font-semibold mb-2">Clinical Significance</h2>
            <p>
                C. dubliniensis is associated with fungemia, endocarditis, and UTIs. Infections are more frequent in patients with compromised immunity such as those undergoing chemotherapy, organ transplantation, or HIV/AIDS. It shows some resistance to azole antifungals, making susceptibility testing important.
            </p>
        </section>

        <!-- Treatment -->
        <section>
            <h2 class="text-xl font-semibold mb-2">Treatment</h2>
            <p>
                Treatment involves antifungal agents such as fluconazole, amphotericin B, or echinocandins. However, resistance patterns may vary, and antifungal susceptibility testing is recommended for effective therapy.
            </p>
        </section>

        <!-- References -->
        <section>
            <h2 class="text-xl font-semibold mb-2">References</h2>
            <ul class="list-decimal list-inside space-y-1">
                <li>Sullivan DJ, et al. "Candida dubliniensis: An emerging yeast pathogen." Microbes Infect. 2004.</li>
                <li>Kaufman D. "Fungal infections in the ICU." Crit Care Med. 2010.</li>
            </ul>
        </section>

        <!-- Back to Home Link -->
        <div class="mt-6">
            <a href="index.html" class="text-green-600 hover:underline">&larr; Back to Home</a>
        </div>

    </main>

    <footer class="bg-gray-200 text-center p-4 mt-6">
        &copy; 2025 UTI PathoDB. All rights reserved.
    </footer>

</body>
</html>
